CCTA Analysis: Current Plaque Volume Tops Plaque Burden for Predicting Heart Attack Risk

Current coronary plaque volume, measured by CCTA, was a better predictor of major adverse cardiac events than baseline or cumulative plaque burden, suggesting a dynamic measure is key to risk assessment.

• Study design and exact patient numbers were not detailed in the provided trade summary.
• The analysis reportedly highlights 'current' plaque measurement as the superior CT-based biomarker for future MACE risk (exact hazard ratios or AUCs not reported in source).
• This finding challenges reliance on a single, static baseline plaque burden measurement for risk stratification.

RadPigeon summaries are original and for information only. They are not clinical advice.